Study
Opening the study…
Study
Opening the study…
The studies most like this one, by the words that set it apart, then the fields they share and the work they cite.
Late mortality comparisons after transcatheter and surgical aortic valve replacement can compare different survivor populations. We bounded these differences using matched low-risk trial estimates. Conditional on the balloon-expandable trial estimates representing potential-outcome marginals, a selection-only binary explanation is infeasible for years 1–7 but feasible for years 5–7. An allocation-to-initiation mixture model with aligned time origins and unrestricted omitted outcomes allows the modeled overall mortality difference to range from -4.77 to 5.27 percentage points. These are conditional identification calculations, not confidence intervals, estimated intention-to-treat effects, or evidence establishing clinical harm; sampling uncertainty, censoring and the interpretation of selected cohorts remain unresolved.
How sensitive is a focused meta-analysis of walking and jogging for depressive symptoms? A registered audit of a fixed public extraction pools 21 direct-comparison trials and 994 participants. Post-treatment Hedges g is -0.762, with a confidence interval from -1.203 to -0.321. Every leave-one-trial-out interval excludes zero, but the usual-care-only interval and the between-study prediction interval include zero. No included trial has an overall low-risk-of-bias rating. These conditional computations support neither a uniform treatment effect nor a treatment recommendation.
Does the evidence compare valve replacement while aortic stenosis is moderate with medical treatment and surveillance, or does it include later severe disease? We audited the original reports behind a recent seven-cohort mortality synthesis. The two cohorts with explicit echo-defined moderate stenosis before intervention contributed 26% of random-effects precision weight. Their descriptive mortality hazard ratio remained 0.51 (95% CI 0.38-0.68) under a common-effect model, with 0.51 (95% CI 0.08-3.16) under a modified Hartung-Knapp model. Restricting severity therefore left the observational point association, but considerable uncertainty remained. One included surveillance cohort retained 72 delayed valve replacements among 220 patients: these control strategies are not uniformly no replacement. This source audit clarifies what the observational evidence estimates; it does not establish that intervening during moderate stenosis improves survival.
Does adding a previously unextracted public registry outcome change the selected-trial evidence for ivermectin in acute outpatient COVID-19? This revised aggregate-data audit incorporates COVID-OUT's reported hospitalization/death endpoint at the common follow-up window, expanding the primary analysis to 7714 records and 98 events. The exploratory pooled risk ratio is 1.107 (95% confidence interval 0.577 to 2.123). All 550 extensions compatible with TOGETHER's separate hospitalization and death margins also include no difference. The newly retrieved appendix does not identify their overlap. A separate denominator sensitivity shows why sparse observed events cannot settle the treatment effect when outcome coverage differs. This is a correction of a targeted audit, not a comprehensive meta-analysis, proof of no effect, or treatment recommendation.
Guaranteed income, regular cash with no conditions, has been tested in many American cities and in national pilots, and its advocates expect it to improve mental health without reducing work. We pre-registered a meta-analysis of randomized trials of flat, unconditional cash in high-income countries, searching databases, registries, and the reports most pilots publish outside journals; 62 trials were eligible and 53 had results. About a year into payments, mental health was better in the cash arms by 0.09 standard deviations (CI 0.041 to 0.139) across 34 comparisons in a random-effects model, but the common-effect estimate, which weights the largest trials most, was -0.002 (-0.023 to 0.018), and smaller trials reported larger effects. Employment changed by 0.599 percentage points (-2.533 to 3.731), and the mental-health effect did not fade during payments. Any mental-health benefit of guaranteed income is small and confirmed only in small trials, and about a year in it does not detectably reduce employment.